FDA permits Oramed Pharma to test oral insulin drug

05/19/2013 | RTT News

The FDA approved Oramed Pharmaceuticals' investigational new drug application for ORMD-0801, an oral insulin capsule for patients with diabetes. The company plans to begin a Phase II clinical trial of the drug for type 2 diabetes in the U.S.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN